Scopus BioPharma Inc. — Form D
Scopus BioPharma Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-12-07. The offering totals $9.8M, of which $9.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-12-07
- Form: D
- Accession: 0001104659-21-147286
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $9.8M
- Amount sold: $9.8M
- Investors: 4
- Date of first sale: 2021-11-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-424033
Issuer
- Name: Scopus BioPharma Inc.
- CIK: 0001772028
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 420 LEXINGTON AVE., NEW YORK, NY, 10170
- Phone: 212-479-2513
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| David S Battleman | Director | New York, NY |
| David A Buckel | Director | New York, NY |
| Robert J Gibson | Director | New York, NY |
| Ira Scott Greenspan | Director | New York, NY |
| Raphael A Hofstein | Director | New York, NY |
| Paul E Hopper | Director | New York, NY |
| Joshua Lamstein | Director | Wayland, MA |
| Ashish P Sanghrajka | Director | New York, NY |
| David P Weild | Director | New York, NY |
| Robert J Gibson | Executive Officer | New York, NY |
| Ira Scott Greenspan | Executive Officer | New York, NY |
| Joshua Lamstein | Executive Officer | Wayland, MA |
| Ashish P Sanghrajka | Executive Officer | New York, NY |
| Joshua R Lamstein | Director | New York, NY |
| Joshua R Lamstein | Executive Officer | New York, NY |
| Paul R Hopper | Director | New York, NY |
| Paul R Hopper | Executive Officer | New York, NY |
| Paul J Hopper | Director | New York, NY |
| Paul J Hopper | Executive Officer | New York, NY |
| Morris C Laster | Director | New York, NY |
| Morris C Laster | Executive Officer | New York, NY |
Other filings by this issuer (5)
More